| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.105 | 23.986 | 22.737 | 25.325 | 33.103 | 39.054 | 47.735 | 58.962 | 59.948 | 58.528 |
| Total Income - EUR | 23.170 | 24.182 | 22.772 | 25.376 | 33.330 | 43.188 | 47.735 | 58.962 | 60.671 | 58.618 |
| Total Expenses - EUR | 14.478 | 20.693 | 19.579 | 20.906 | 24.140 | 26.969 | 26.914 | 31.164 | 34.720 | 37.100 |
| Gross Profit/Loss - EUR | 8.692 | 3.489 | 3.193 | 4.471 | 9.190 | 16.219 | 20.821 | 27.798 | 25.951 | 21.518 |
| Net Profit/Loss - EUR | 7.998 | 2.764 | 2.093 | 3.709 | 8.190 | 15.018 | 19.620 | 26.329 | 25.356 | 20.944 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ocular Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.847 | 16.804 | 11.406 | 6.663 | 1.498 | 431 | 253 | 85 | 0 | 1.994 |
| Current Assets | 8.510 | 3.541 | 4.412 | 7.666 | 9.944 | 15.353 | 20.029 | 27.595 | 26.647 | 20.263 |
| Inventories | 1.044 | 1.463 | 1.563 | 2.142 | 2.041 | 2.357 | 1.519 | 2.117 | 2.138 | 2.793 |
| Receivables | 0 | 0 | 0 | 0 | 4 | 4 | 16 | 34 | 1.060 | 51 |
| Cash | 7.466 | 2.078 | 2.848 | 5.523 | 7.899 | 12.993 | 18.494 | 12.264 | 23.449 | 17.419 |
| Shareholders Funds | 9.816 | 2.817 | 2.146 | 3.761 | 8.245 | 15.071 | 19.672 | 26.382 | 25.409 | 20.996 |
| Social Capital | 45 | 45 | 44 | 43 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 541 | 17.527 | 13.672 | 10.568 | 3.197 | 713 | 609 | 1.298 | 1.238 | 1.261 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Ocular Plus Srl